Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients — Stella

Home/Hepatitis B, Chronic/

View on ClinicalTrials.gov

Recruiting

Back to Hepatitis B, Chronic trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Department of Infectious Diseases, The Third Affliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong

Key details

Phase

Post-approval study

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University

Enrollment target

~5,000 participants

Started

January 2022

Primary completion

December 2026

Age range

18 Years – 60 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.